1Contamination control
The sanitation programs were not adequately designed to identify and/or reduce the risks of contamination.
Inspection Record
Delpharm Montréal Inc. — Health Canada Inspection Findings
View the regulator's official source The source document is always the basis for judgement.
Findings
2Laboratory and QC controls
The quality control department did not undertake all of the required activities. The protection of products and/or materials from contamination was inadequate.
3Equipment and facility
The availability, content and/or maintenance of the quality agreements between the supplier, fabricator, tester, packager, labeller, distributor, importer, and/or wholesaler was inadequate.
4Laboratory and QC controls
The creation, maintenance, processing, and/or review of laboratory data was inadequate.
5Complaint and recall handling
The assessment, recording, follow-up, and/or investigation of complaints and/or other information about potentially defective products was inadequate.
6Material and supplier control
The verification and dispensing of raw materials by qualified staff was inadequate. Measuring devices were not regularly checked for accuracy and precision. The protection of products and/or materials from contamination was inadequate.
About this record
Extracted automatically from the document of the Health Canada inspection on 2021-04-19. The source is available at the link above.
This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.
Translation and classification are automated and may differ in nuance from the source.
